| Names | |
|---|---|
| Preferred IUPAC name | 2,3-Dichloropyridine |
| Other names | 2,3-Pyridinedichloride 2,3-Dichlor-1-hydropyridin 2,3-dichloro-pyridine 2,3-dichloropyridine |
| Pronunciation | /ˌtuː θri daɪˌklɔːrəˈpɪrɪdiːn/ |
| Identifiers | |
| CAS Number | 1834-75-7 |
| Beilstein Reference | 120922 |
| ChEBI | CHEBI:132797 |
| ChEMBL | CHEMBL48979 |
| ChemSpider | 16316 |
| DrugBank | DB14642 |
| ECHA InfoCard | 100.013.763 |
| EC Number | 211-309-7 |
| Gmelin Reference | Gmelin 209983 |
| KEGG | C06337 |
| MeSH | D017174 |
| PubChem CID | 13808 |
| RTECS number | UY9625000 |
| UNII | VL3OY12L3E |
| UN number | UN3276 |
| Properties | |
| Chemical formula | C5H3Cl2N |
| Molar mass | 147.00 g/mol |
| Appearance | Colorless to pale yellow liquid |
| Odor | Characteristic |
| Density | 1.4 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | 1.92 |
| Vapor pressure | 0.41 mmHg (at 25°C) |
| Acidity (pKa) | 3.40 |
| Basicity (pKb) | 3.62 |
| Magnetic susceptibility (χ) | -49.2·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.553 |
| Viscosity | 0.926 cP (20°C) |
| Dipole moment | 1.99 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 160.7 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | −17.6 kJ·mol⁻¹ |
| Std enthalpy of combustion (ΔcH⦵298) | -2421 kJ/mol |
| Hazards | |
| Main hazards | Harmful if swallowed, causes skin and eye irritation, may cause respiratory irritation, toxic to aquatic life. |
| GHS labelling | GHS02, GHS07 |
| Pictograms | Acute Toxicity, Irritant |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H332 |
| Precautionary statements | Precautionary statements: P261, P280, P305+P351+P338, P304+P340, P312 |
| NFPA 704 (fire diamond) | 2,3-Dichloropyridine: "2-2-0 |
| Flash point | 70 °C (closed cup) |
| Autoignition temperature | '540 °C' |
| Explosive limits | Explosive limits: 2.7–14% |
| Lethal dose or concentration | LD50 oral rat 727 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral rat LD50 1340 mg/kg |
| NIOSH | PY9550000 |
| PEL (Permissible) | Not established |
| REL (Recommended) | 0.5 ppm |
| IDLH (Immediate danger) | Unknown |
| Related compounds | |
| Related compounds | 2-Chloropyridine 3-Chloropyridine 2,6-Dichloropyridine 3,4-Dichloropyridine 2,3,5-Trichloropyridine 2-Bromopyridine 2,3-Dibromopyridine |
| Category | Details | Manufacturer Commentary |
|---|---|---|
| Product Name & IUPAC Name | 2,3-Dichloropyridine IUPAC: 2,3-dichloropyridine |
This compound is produced industrially using chlorination routes or from appropriate substituted starting materials. Selection of the synthetic pathway generally hinges on feedstock consistency, cost, and downstream impurity manageability. |
| Chemical Formula | C5H3Cl2N | Batch analysis tracks the empirical formula to verify molecular integrity through QC checks. Composition supports robust fingerprinting for in-process and post-process assay alignment, especially when transitioning between batch and continuous processes. |
| Synonyms & Trade Names | 2,3-DCP, Pyridine, 2,3-dichloro-, 2,3-dichloro-pyridine | Synonyms cited here reflect both regional and application-driven nomenclature adopted in raw material procurement, global shipping documents, and technical dossiers. Trade name differentiation is primarily subject to customer and contract specification. |
| HS Code & Customs Classification | 2933.39 | For export and regulatory compliance, this commodity is routinely declared under this HS code, which specifically covers heterocyclic compounds with nitrogen hetero-atom only; pyridine derivatives. Assignments may flex based on minor formulation or blend for specific regions. Documentation at dispatch includes chain-of-custody traceability. |
2,3-Dichloropyridine presents process variability in impurity profiles tied directly to the chlorination conditions and pyridine source. For any commercial-grade offering, batch consistency is assessed using chromatographic techniques, with impurity cutpoints reflecting the customer's end-use—pharma, agro, or specialty intermediates. Choosing starting materials with minimum isomeric and aromatic impurities narrows downstream purification load, directly impacting cost-per-kilogram and batch-to-batch reproducibility.
Manufacturing routes are typically selected based on both scalability and environmental compliance: direct chlorination steps demand rigorous containment, while alternative multistep syntheses may attract extra waste minimization requirements. Key control points focus on temperature, solvent choice, and addition rate; deviations in any of these often elevate byproduct formation, calling for either in-line monitoring or end-of-batch recirculation. Purification steps—mainly distillation under reduced pressure or recrystallization—aim to meet customer impurity profiles, which can vary depending on whether the product is destined for a high-purity application or a technical-grade formulation. Release specifications for each lot follow company-internal QC protocol and buyer request, rather than a universal published threshold.
Performance in downstream synthesis hinges on grade selection—pharmaceutical processors scrutinize for trace-level residuals, agrochemical formulators permit broader specification windows. Storage and handling guides are developed jointly with customers based on intended formulation environments and stability data. Container selection and logistics planning observe regional regulatory requirements, especially for hazardous cargo routing and customs clearance under the 2933.39 HS code.
2,3-Dichloropyridine typically presents as a crystalline solid or low-melting solid, shifting to a clear, pale yellow-to-brown liquid above its melting threshold. Color and odor may vary with grade and purity, reflecting trace impurities or residual solvents from synthesis. Higher-purity grades exhibit a lighter color and sharper pyridine-like odor, which can intensify during bulk transfers or agitation.
The actual transition temperatures observed during production and in QC depend on impurity content. Industrial batches may demonstrate slight shifts in these values due to byproduct carryover or incomplete drying. Consistency is monitored batch-wise for critical applications. Melting and boiling points are sensitive to grade, process, and formulation water content, and deviations can signal the presence of residual chloropyridine isomers.
Care is taken in reporting flash points for logistics teams handling bulk volumes. Density measurements are used frequently in the tank farm for inventory calculations and blending; typical values are grade-specific.
2,3-Dichloropyridine remains stable under inert gas and ambient dry conditions during storage and bulk filling. It reacts readily with strong nucleophiles and acids, with batch-to-batch reactivity trends providing quality cues. Moisture levels must be tightly controlled since hydrolysis can generate corrosive byproducts, compromising both product and container integrity.
Solubility in water is limited, and solubility tests use a range of industrial solvents depending on downstream application. Slurry formation and dissolution rates differ by purity and particle size; tracked routinely during formulation stage. Operations follow solvent compatibility charts to limit solvent-extractable impurities entering fine chemical synthesis routes.
Specification ranges for 2,3-Dichloropyridine differ between pharmaceutical, agrochemical, and technical-grade products. Each grade maintains tailored maximums for key residual isomers, moisture, and solvent carryover. Product release incorporates internal grades and end-use requirements. Precise values depend on customer and regulatory specifications, especially for regulated applications.
| Parameter | Technical Grade | Pharma Grade |
|---|---|---|
| Purity (GC area %) | Typical above 98% | Subject to order-specific minimum |
| Water | Routine Karl Fischer below threshold | Tighter on request |
| Total Chloropyridine Isomers | Limited per process capability | Internally set based on risk |
Impurity specifications are tightly linked with the route of synthesis and plant practice. Chief impurities originate from byproducts in chlorination or from incomplete separation of isomers. These are structurally related and their relative levels track process consistency. Profiles are reviewed per batch using chromatographic fingerprinting, with limits adjusted by end-use sensitivity (API intermediates vs non-critical technical uses).
Routine QC relies on GC, HPLC, NMR, and moisture analysis protocols. Test frequency is set to ensure release confidence, aligned with batch size and criticality. Applied methodologies reflect international standards when required by customer or region, and in-house validated methods for technical grades.
Sourcing for 2,3-Dichloropyridine focuses on consistently qualified chlorinating agents and pyridine raw material. Supplier assessment considers both purity and trace contaminant risk, especially where these may influence downstream yields or safety margins. Cross-contamination with other halopyridines in multipurpose plants is a recognized challenge.
Most production relies on selective direct chlorination or substitution reactions starting from 2,3-dichlorinated pyridine derivatives. Route choice is driven by availability and economic stability of pyridine feedstock, and by regulatory expectations surrounding precursor control. Selection also considers minimization of multi-isomer byproduct streams, which complicate purification and compliance.
Key control points include reaction temperature, rate of chlorinating agent addition, and real-time isomer ratio tracking. Crude filtrate undergoes staged distillation and solvent washes tailored to product grade. For pharmaceutical and electronic applications, further purification employs fractional crystallization or high-vacuum distillation. Each batch receives in-process checks to control color, titer, and isomer profile, ensuring reproducible plant output.
QC inspects both intermediates and final product using multi-point chromatographic and wet-chemistry protocols. Only those batches that meet internal release standards—rigid for regulated markets or per customer contract—advance to packaging and shipping. Release documentation includes full impurity and moisture certificates with traceability back to the original raw material.
Common transformations with 2,3-Dichloropyridine include nucleophilic aromatic substitution, amination, and cross-coupling. Most process chemists exploit the differentiated reactivity of the 2- and 3-chloro positions for stepwise functionalization downstream. Technical staff collect customer feedback on actual yields and process times in specific applications to fine-tune product specifications.
Typical conditions involve polar aprotic solvents and phase transfer or transition metal catalysts. Temperature and pressure ranges fall within standard plant safety margins, but scale-up requires strict attention to exothermicity and gas release. Variability in exotherm profiles ties back to trace contaminants, which are minimized through chromatographic pre-qualification of all outgoing batches.
This intermediate feeds into high-value drug, pesticide, and material science pipelines. Downstream chemistries draw value from the controlled reactivity and low matrix contamination of properly manufactured 2,3-Dichloropyridine. Customer-specific customization depends on knowledge of possible residual metal or halide loads from the original reaction route.
Ambient dry storage with regulated ventilation and drum inertization controls both product stability and workplace exposure. Polyethylene-lined steel and selected fluoropolymer containers offer suitable compatibility for avoiding extractables and corrosion. Segregation from acids and oxidants is monitored during warehouse audits.
Customers that return packaging for reuse receive compliance checks for potential cross-contamination. Any detectible degradation product—often revealed by color shift or turbidity—triggers batch hold or requalification before shipment.
Shelf life depends on moisture, light exposure, and packaging seal integrity. Degradation is observed as darkening, odor intensification, or gel-phase separation in drums, with such signs prompting quarantine and investigation. Periodic stability studies inform recommended shelf life updates for each grade and market.
Operators handling 2,3-Dichloropyridine encounter defined inhalation and dermal hazards, with classification communicated in safety data and on bulk drum labeling. At the plant level, hazard information influences PPE requirements and work zone controls, with regular refresher training to address any process or formulation changes. Personnel apply spill management kits tailored for chlorinated solvents.
Toxicological evaluation includes data from species-specific studies submitted internally and to regulators as requested. Exposure limits for factory and logistic staff follow both regulatory guidance and internal risk-based calculations, reflecting the cumulative exposure risk of workers across shift patterns and bulk handling operations.
Direct skin and respiratory contact requires elimination through closed transfer, LEV systems, and pre-transfer risk reviews. Product stewardship extends to end-customers through technical support on safe handling, PPE selection, and emergency decontamination protocols, tailored to installation and throughput size.
2,3-Dichloropyridine production involves chlorination of pyridine or upstream chloropyridines, and production scale hinges on access to high-purity starting materials, reactor throughput, and utilities management. Annual output fluctuates with scheduled maintenance, feedstock price cycles, and output planning for specialty versus standard grades. Orders involving pharmaceutical precursors or electronic grade batches may require extended lead times for dedicated equipment or process validation, compared with typical industrial-grade production.
Raw material security (notably pyridine derivatives and chlorinating agents) forms the foundation of batch planning and annual capacity projections. Supply interruptions or regulatory curbs (particularly in regions enforcing chlorinated intermediate controls) can affect batch scheduling.
Lead time varies according to the grade, volume, and line changeover requirements. Standard industrial-grade batches can be scheduled biweekly, while specialty grades involving segregated purification steps or high documentation demand longer. MOQ reflects plant logistics and downstream solvent handling protocols, with larger pack sizes intended for manufacturers integrating at scale, while pilot projects may require negotiation for bespoke quantities.
2,3-Dichloropyridine typically ships in steel or HDPE drums with nitrogen blanketing when moisture or oxygen sensitivity needs containment. UN-certified drums demanded for regulated markets undergo mandatory leak, impact, and compatibility tests before release. Ampoule or lined canisters become necessary for highest purity or agrochemical intermediates, subject to customer specification and regional transport regulations.
Export shipments follow INCOTERMS aligned with destination, bulk versus packed mode, and customer warehousing infrastructure. Payment terms are shaped by credit risk profile, past transaction history, and timing relative to global demand seasonality (notably during agricultural synthesis campaigns or pharma launches). Hazardous goods classification impacts both booking and routing, introducing compliance checks at each leg.
Raw material cost anchors on market price trends of pyridine or chlorinated pyridines and the availability and regulatory clearance of typical chlorinating agents. Market tightness for either precursor—often driven by demand from associated segments (pharma, agro, electronics)—directly moves production costs. Chlorination conversion yield, precursor purity, and efficiency gains during purification collectively impact unit cost and allowable price discount windows. For grades demanding enhanced analytical purity, higher solvent and labor inputs create visible step-ups in cost.
Price movements in 2,3-Dichloropyridine arise chiefly from upstream feedstock volatility, energy cost spikes (notably during Q2–Q4 in major producing regions), and regulatory pushbacks on chlorinating agents or waste-handling. Supply crunches from plant shutdowns or force majeures ripple rapidly through supply agreements, particularly for contract-customers with rolling blanket orders.
Grade, purity, and certification create tiered pricing. Technical/industrial grade products supplied for polymer intermediates or general org syn see fewer batch-specific quality control steps, reflected in lower price tiers. High-purity, documentation-backed deliveries for pharma or veterinary end-use require more analytical release controls, traceability, and often regulatory inspection readiness, all contributing to cost. Packaging format also influences the total delivered price, especially for UN-certified, ultra-low contamination requirements.
Batch-to-batch impurity profiles and trace-level analytical results determine eligibility for high-value segments. Certificate of Analysis referencing key contaminants or tailored QC protocols—especially for the Japanese or American market—may drive price bands, since not all production runs meet these thresholds without dedicated campaign manufacture. Clients requesting smaller, more rigorously certified packaging (for clinical use or API synthesis) see premium markups reflecting extra handling, validation, and logistics controls.
Major production centers remain in East Asia (with China holding the largest decentralized capacity), India (focused on backwards-integrated pharmaceutical circuits), and Europe (catering to specialty syntheses). The US market acts more as a net importer, typically preferring documented and cGMP-linked sources, which elevates regulatory and logistical cost.
Price outlook depends on global chlorinating agent markets, downstream pharmaceutical project launches, and regulatory frameworks governing technology and waste streams, especially in Asia and the EU. Upticks in regulatory cost, energy inputs, and limited plant expansions point toward gradually firmer price floors, while competitive pressures from new entrants in India and China may increase price volatility in mid-tier grades. Documentation and analytical certification layers will continue to set apart pricing for regulated markets through 2026.
Trend analysis draws on internal production statistics, regional trade reports, contract-client feedback, and active supplier notifications referencing price changes, regulatory alerts, or shutdown event data. Frequent cross-verification comes from downstream manufacturers and import-export databases for spot volume and transaction benchmarks.
Recent quarters have seen increased scrutiny on chlorinated pyridine intermediates in response to regional environmental controls and a series of plant compliance checks across East Asian manufacturing hubs. Chinese provinces have temporarily curtailed production in affected chemical parks, driving up short-term spot prices. The expansion of Indian contract manufacturing capacity for custom syntheses has introduced more flexible term offers but added unpredictability to logistics timelines.
European and North American buyers face enhanced reporting requirements under REACH and TSCA, with special attention paid to allowable trace residual solvents and impurity content. Updated safety assessments have led to more frequent batch certification requests. REACH pre-registration and full dossier supply have become non-negotiable for continued market access in the EU for technical/intermediate grades.
Manufacturers invest in in-line monitoring for chlorinating agent dosage, real-time impurity mapping, and traceable batch record archiving to comply with global regulatory regimes. Internal audits target solvent recycling and emissions controls to tighten compliance. Expanded partnerships with specialty logistics providers support secure handling of certified product shipments and expedite documentation for more demanding markets.
2,3-Dichloropyridine serves as a critical intermediate across several sectors. Agrochemical synthesis leverages its chlorinated pyridine backbone for the development of herbicides and fungicides. In pharmaceutical manufacturing, it acts as a fragment for producing active pharmaceutical ingredients, often in multi-step syntheses where strict impurity control and lot traceability take priority. The compound also finds utility in the materials sector, particularly in the synthesis of specialty coatings and advanced dyes, where solvent compatibility and downstream reactivity often dictate the minimum specification for purity and residual moisture.
| End Use Sector | Required Grade | Parameter Focus |
|---|---|---|
| Agrochemicals | Technical or Industrial Grade | Consistent assay, controlled residual organics, defined trace metals |
| Pharmaceuticals | High Purity Grade | Tight impurity profile, low residual solvents, stringent batch reproducibility |
| Materials Synthesis | General Purpose or Custom Grade | Assay balance vs. cost, compatibility with target formulation, moisture limits |
Agrochemical formulators usually prioritize process yield and consistent active content, accepting moderate residual by-products if downstream removal is feasible. Pharmaceutical process engineers demand a well-defined profile of individual impurities; each lot receives additional scrutiny for compliance with international and customer-specific regulatory and toxicological limits. Materials processors focus on handling attributes—moisture content, particle cut, and in some cases, low halide by-products which might affect further reaction control.
The technical team must map the precise downstream use—whether as a reaction intermediate, coupling agent, or direct add-in. Only by defining if the chemical is entering a regulated pharmaceutical process, a bulk agricultural synthesis, or a materials pilot line can the search begin for a grade specification aligned with both process economics and regulatory exposure.
Careful screening of the intended market and compliance landscape is necessary. Pharmaceutical end uses call for increased scrutiny, often requiring vendor qualification audits, documentation for traceability, and possible validation to (c)GMP or similar standards. Agrochemical and industrial customers might reference their own internal acceptance limits, yet prefer long-term batch track records and access to impurity fingerprinting data upon request.
Purity requirements shift according to the synthetic route and end-product criticality. High-value or sensitive downstream chemistry pushes for a higher-grade selection, with control over key organic impurities and moisture. Cost-benefit analysis must always factor in any potential impact of trace residuals on reaction yields, waste generation, and formulation stability. Technical teams assess historic out-of-spec issues or technical bottlenecks that could drive the choice for a more tightly specified grade. Cross-checking the assay, individual impurity limits, and volatile content for each batch type is critical.
Process scale and campaign duration often determine sourcing strategy. Pilot plant runs or high-volume agricultural product synthesis permit more flexibility, as a pragmatic balance between absolute purity and overall project budget becomes the key driver. For low-volume, high-potency drug intermediate supply, price-per-kilogram weighs less than supply chain stability and documentary support.
Before full-scale order commitment, process managers or QC labs test a production sample under their actual process conditions. Real-world validation evaluates both analytical conformity—verified by certificate of analysis and in-house QC—and operational outcomes such as reaction kinetics, filtration quality, or tolerance to trace impurities. Feedback from this qualification loop often leads to fine-tuning of the order specification, supporting a reliable long-term partnership for ongoing supply.
In our facility, quality control walks a fine line between regulation and real-world performance. Industrial-grade 2,3-dichloropyridine output hinges on raw material consistency, equipment calibration, and batch-by-batch monitoring. Our internal operations rely on established quality management systems, which permit reproducible results in every production cycle. Facility and process audits hold significant weight throughout our yearly planning, providing a record of adherence beyond routine paperwork.
Certifications for 2,3-dichloropyridine often trace back to end-use and export requirements. For fine chemical and pharmaceutical intermediate applications, certificates of analysis (COA) are batch-defined and detail the principal assay, moisture by Karl Fischer, heavy metals, and residual solvent levels—a direct outcome of our in-process controls and purification steps. When customers specify compliance with particular regional or pharma regulations, the manufacturing line adjusts test protocols and reporting according to the specification negotiated. Any declaration of compliance always references the actual test batch, never a generic template.
We support every shipment with batch-specific analytical reports, in addition to safety data documentation. COA, technical data sheets, and regulatory reports are tied to production logs and retained samples, giving end users a continuous link back to the process itself. We accommodate requests for statements such as origin certificates, change controls, or audit logs as needed, drawing on real documentation generated during manufacturing. This approach ensures every claim about product quality is verifiable by both process data and retained reference material.
Industrial buyers define their schedule around predictable supply. In 2,3-dichloropyridine plants, production planning blends campaign and continuous operation based on customer volume and project needs. For long-term contracts, core capacity is allocated with provisions for process interruptions and raw material fluctuations. On the flexibility side, we introduce slot-based or minimum campaign batch approaches, so both stable and project-specific demand is met without compromising core output. Real-time inventory status and capacity availability, as monitored by production line logs, are always available to partners during agreement negotiation or project planning.
Output reliability reflects upstream raw material control and internal scheduling. Direct sourcing contracts with key suppliers, along with redundancy in critical raw material stocks, define the backbone of our supply chain. Any claims of “stable supply” mean active management of both the reactor occupancy and the purification train, not just raw tonnage. Production run transitions and shift handovers are cross-checked against both expected and actual output, with documented controls at each stage. For customers with planned scaling or seasonal spikes, the production calendar is coordinated directly.
Sample evaluation usually starts with a technical dialogue clarifying target assay, impurity profile, and any downstream formulation constraints. Once requirements are established, samples are drawn from retained reference batches or, for specialty grades, from a dedicated test run. Each sample ships with individual batch reports and supporting documentation, not pilot plant composites. Application feedback cycles between the technical teams on both sides drive further optimization in purity profile, granule size, or moisture control, as needed.
Business relationships rarely fit a single model. Flexible cooperation often assumes a framework order or rolling forecast arrangement, where minimum batch quantity and delivery dates flex according to downstream demand signals. Consignment arrangements, VMI (vendor managed inventory), and dual-supply strategies remain open for partners with exposure to market swings or sensitive regulatory timings. In technical collaboration, custom grade development is tied directly to process R&D teams, so process parameters can be tuned for final use case requirements without running separate research batches. Regular production review meetings include output, quality incidents, and process improvement logs, all shared for transparent planning and performance benchmarking.
In our recent development initiatives, the focus for 2,3-dichloropyridine centers on pharmaceutical intermediates—especially for targeted oncology and antiviral compounds. Researchers in agrochemical synthesis increasingly turn to this pyridine derivative as new herbicide and fungicide frameworks require selectivity that standard halogenated aromatics cannot deliver. Project teams pay close attention to reaction selectivity and minimization of unwanted isomer formation, since application-specific grades differ substantially in regulatory acceptance and downstream purification burden.
Custom synthesis programs have identified 2,3-dichloropyridine as a versatile building block for heteroaromatic ligands, advanced materials, and certain specialty dyes. Material science sectors pursue improved coordination polymers and catalyst supports derived from this structure, targeting durability in harsh process environments. Pharmaceutical development groups emphasize chiral pathway exploration; success rates hinge on impurity control during halogenation and substituent exchange. These technical demands have shifted our pilot batch focus towards adaptable purification and real-time monitoring strategies.
Primary technical hurdles persist around selective chlorination and control of trace impurities, especially polychlorinated pyridines and residual starting material. For high-purity or custom synthesis applications, trace levels can dictate downstream efficacy or trigger regulatory review. Process optimization work has recently yielded improved phase-transfer methods, reducing the formation of mono- and higher-order chlorinated byproducts. Each scale-up stage places strong emphasis on batch-to-batch reproducibility and tailored process controls, with ongoing collaboration between our R&D and analytical teams to systematically identify and reduce impurity carryover.
We expect stable demand in pharmaceutical and agrochemical sectors, driven by ongoing approvals of new halogenated intermediates. Shift in regulatory frameworks for agricultural chemicals in key regions directly influences grade requirements and product certification needs. Price and demand volatility link closely to fluctuations in global supply chains for core raw materials such as 2-chloropyridine and chlorinating agents. New applications in electronic materials and custom synthesis sectors promise incremental volume growth, especially for grades with defined impurity profiles and enhanced lot traceability.
Production practice continues to transition from legacy batch halogenation to continuous or semi-continuous processes, aiming to minimize reaction footprint and improve yield consistency. Automated process control strategies using in-line spectroscopy facilitate earlier impurity identification and reduce manual intervention. We benchmark every new production run for consistency against historical analytical profiles, enabling a closed-loop feedback system to adjust feed ratios and purification endpoint dynamically.
Raw material sourcing now faces sharper scrutiny, with procurement aimed at minimizing upstream environmental load and supplier carbon footprints. Solvent recovery and reagent recycling have become mandatory elements in the process design, not just cost-saving measures. Where process change risks cross-contamination or storage hazard, every transition stage undergoes joint scrutiny by production and EH&S teams before implementation. Our long-term view stresses solvent minimization and reagent replacement with lower-toxicity alternatives, subject to maintaining product criticality for the target application.
Application specialists are involved from the initial inquiry stage to support optimal grade selection, based on intended downstream synthesis route or final product context. Standard inquiries relate to compatibility with specific synthetic transformations, impurity limitations for regulated markets, and adaptivity to custom purification schemes. Detailed technical dossiers (including analytical methodology and pre-release QC protocols) are provided for ongoing customer evaluations or validation batches.
Regular engagement includes site visits or remote troubleshooting for scale-up challenges, impurity removal, and yield loss diagnostics. Process chemists share application-specific guidance, especially where grade or impurity range influences catalyst poisoning or side reaction rates. For novel downstream reactions, our lab team can trial simulated workflows to advise on optimum processing parameters or recommend adjustments in product grade specification to meet unique technical thresholds.
Every shipment’s batch documentation and traceability extend beyond initial delivery—retained samples and full release records are archived for all product lots, supporting customer QC troubleshooting and retrospective process review. If any change in raw material source or process route is required, formal notification, supplemented with new performance and impurity data, is supplied before changeover. Multidisciplinary teams monitor customer feedback and field returns to capture trends in handling, storage stability, or off-spec occurrence, feeding these data back into the process improvement cycle.
In our facility, manufacturing 2,3-Dichloropyridine starts with defined raw material selection and tight process parameters. Technicians run multi-step chlorination using automated systems that continually monitor temperature, pressure, and reaction time. Full visibility into every batch ensures clear traceability and minimizes the chances of off-spec product. Our investment in closed-system handling cuts down on impurities and moisture, supporting downstream users in fine chemical, agrochemical, and pharmaceutical sectors that require high-purity inputs.
2,3-Dichloropyridine acts as a vital intermediate for several high-value sectors. Agrochemical formulators rely on it for constructing selective herbicides and crop-protection agents, demanding consistency at the active ingredient stage. The pharmaceutical industry uses this molecule as a core building block in synthesizing anti-infective and anti-inflammatory agents. Dye manufacturers and specialty chemical companies often approach us for this compound because production process stability translates to fewer deviations in their own syntheses.
Chemists continually check for purity, appearance, and chemical structure using in-house GC and NMR. These checks guide batch release decisions. The plant lab maintains strict calibration routines with documented verification steps, reducing the risk of cross-contamination. As a manufacturer, we value repeatability over unsubstantiated claims: customers count on parcels that align with agreed specifications time and again, which directly supports their yield and output targets.
Industrial buyers expect robust packaging and reliable shipment. We fill and seal product in corrosion-resistant drums, ensuring each shipment arrives intact whether it’s crossing cities or international borders. Shipments match market demand. Whether a customer needs standard drum lots or bulk containers, dedicated storage sections in our warehouse allow us to stage and release orders on fixed schedules. That consistency helps partners plan procurement with confidence, knowing timing fits their own production cycles.
Process changes, raw material shifts, and new reaction schemes sometimes raise technical questions. Our technical support team—drawn from both plant operations and research labs—works directly with customers’ process chemists and engineers. If a plant intends to scale up, we walk through compatibility, reactivity, and storage guidelines in detail, drawing from in-house data and shared application experience. This approach solves problems quickly and helps partners avoid unnecessary delays or scale-up surprises.
Across industries, procurement and manufacturing leaders seek risk reduction—especially in volatile supply chains. Because we direct every step of 2,3-Dichloropyridine production and shipment, purchasing teams benefit from fewer handoffs and transparent communication channels. Distributors working with us obtain a predictable supply—supported with full batch documentation—to meet regulatory and inventory needs. Production planners and procurement teams gain flexibility to align inventory exactly to usage without overstocking, thanks to our managed production scheduling and logistics support.
| Aspect | Our Commitment |
|---|---|
| Manufacturing Control | End-to-end process management and in-house synthesis |
| Product Quality | Multi-point analytical verification and batch consistency |
| Applications | Pharmaceutical, agrochemical, dyes, specialty chemicals |
| Packaging | Sealed, chemical-resistant drums and flexible shipment sizes |
| Supply Chain Integration | Direct dispatch, inventory alignment, technical guidance |
A manufacturing-led approach lets us offer 2,3-Dichloropyridine with reliable supply and strong technical backing, meeting the practical priorities of commercial and industrial buyers whose operations depend on consistency, safety, and partnership built on real expertise.
Producing 2,3-dichloropyridine from the chlorination of pyridine involves a careful balance between reaction conditions, raw material choices, and effective downstream purification. In factory practice, our technical team tracks not only the target compound but also the inevitable by-products and impurity trends. This oversight drives product reliability and process refinement across every batch.
Chlorinating pyridine does not yield only the desired dichloro product. Chlorination often generates several related impurities by rhythm of the reaction mechanism. Mono-chloropyridines (such as 2-chloropyridine and 3-chloropyridine) show up as incomplete chlorination products. Over-chlorination produces trichloropyridines, with 2,3,5-trichloropyridine and 2,3,6-trichloropyridine observed when excess chlorine is present or temperatures run above optimal thresholds. Unreacted pyridine remains if conversion falls short or mixing allows channeling.
Nitrogen-containing heterocyclic by-products arise from side reactions or ring-opening under harsh conditions. Hydrochloric acid and water trace levels may accompany the main product if they are not effectively removed during drying. These impurities affect chemical behavior in subsequent applications, so controlling them takes priority from a manufacturer’s perspective.
Our technical staff assesses each production lot against tight tolerance bands for assay (content), related substances, residual solvents, moisture, color, and pH. The typical purity target for commercial-scale 2,3-dichloropyridine exceeds 98% by GC area normalization. Individual unspecified impurities stay restricted below 0.5%. Total impurities are monitored stringently, and known by-products can be selectively quantified when client processes demand it.
Residual solvents, especially from extraction and washing steps, are kept at trace levels. Standard measurement uses headspace GC aligned with internal compliance norms. Moisture—critical for stability and reactivity—is determined using Karl Fischer titration, typically maintained below 0.5%. Consistent color appearance reflects whole-process control; off-color batches suggest process anomalies. Any abnormal hue prompts rework or investigation.
We have optimized chlorination parameters — chlorine flow, temperature profile, and reaction time — to suppress side-product formation. Inline sampling and GC monitoring during synthesis catch deviations early. For purification, multi-stage distillation under reduced pressure selectively removes mono- and trichloro analogs, while continuous washing and drying strips traces of inorganic by-products. Our experience shows that most impurities can be reduced to below quantifiable limits by holding operational discipline at each stage. Each improvement in process repeatability directly benefits the purity profile available to customers.
Clients in pharmaceutical, agrochemical, and specialty materials sectors count on consistency. Our batch release documentation provides full impurity profiles for traceability. We regularly review historic analytical data to optimize both yield and impurity control, feeding back lessons learned into future campaigns. This cycle of measurement, control, and adjustment keeps our 2,3-dichloropyridine compliant with the expectations of demanding formulation environments.
As a chemical manufacturer specializing in chlorinated pyridine derivatives, we handle bulk synthesis and export of 2,3-Dichloropyridine every production cycle. Over several years of serving the pharmaceutical, agrochemical, and fine chemical sectors, we’ve learned that clarity on minimum order quantities and reliable delivery timelines means as much to our partners as the material’s purity does.
We set our minimum order for 2,3-Dichloropyridine at 200 kilograms per batch. This volume reflects process efficiency at the plant level, cost of raw material procurement, and our commitment to maintaining consistent quality across every lot. Smaller runs drive up per-unit cost and may introduce variability in purity and moisture content. We have engineered our reactors for this scale, so every batch receives full quality assurance routines including GC-HPLC testing and impurity checks.
Clients in active pharmaceutical and crop protection intermediates usually request loads above this threshold. For cooperative projects and recurring agreements, our team can review and discuss increased batch sizes, tank loading, or ISO tank containerization, allowing marine or land transport flexibility.
From confirmed purchase order to ship-ready goods, the production cycle typically runs about 3 weeks for 2,3-Dichloropyridine. For stocked batches or regular partners, we can sometimes shorten this interval. More often, our lead time includes new synthesis, purification, and thorough lot release analytics. Seasonal factors, such as the raw material supply of 2,3-Dichloropicoline or logistics during port congestion, have a real impact. We maintain extra buffer stocks of critical raw inputs for this reason, aiming to keep our lead times reliable even when market demand spikes.
Packing is done using UN-certified HDPE drums or IBC totes to meet bulk transit needs. Our technical team oversees closed filling operations, nitrogen blanketing, and final drum or tote sealing. Every shipment leaves the facility with a detailed certificate of analysis showing key parameters like assay, solvent residue, and related substances.
Bulk production requires coordination and predictable scheduling. Batch scale aligns upstream procurement with finished goods requirements, while sensible minimum order quantities help maximize reactor uptime and laboratory throughput. This approach reduces downtime, controls overhead, and, most importantly, helps us keep pricing competitive without sacrificing test records or traceability.
In years of manufacturing, we’ve also found that transparency around lead time helps our customers plan their own downstream synthesis campaigns. No one benefits from vague promises or shipment delays. Our focus is to bring clarity, so procurement and project management teams can align their calendar with actual goods flow.
For partners who anticipate fluctuating requirements, we offer forward contracts and scheduled call-off orders. This lets us plan the raw material stream and reserve vessel time, smoothing out supply. In urgent cases, our plant can sometimes run extra shifts, but consistent forecasting always leads to better outcomes for all involved.
Whether working with an established multinational or a new specialty player, our direct manufacturing approach means every order originates at our reactor lines—not from stockpiles at third-party warehouses. This maintains rigorous quality protocols and gives clients one point of traceability back to the original production record.
As a chemical manufacturer with direct experience producing and exporting 2,3-Dichloropyridine, we deal with transportation, storage, and regulatory questions on a practical, daily basis. Shipping a hazardous material such as this involves more than just moving drums from one country to another. Stringent rules and an ever-evolving regulatory landscape shape how our logistics teams react and adapt to ensure compliance at all touchpoints.
2,3-Dichloropyridine falls under hazardous goods classification due to its chemical properties. On any international route, this means compliance with global conventions—primarily the IMDG Code for sea shipments, IATA regulations for air, and ADR/RID for road and rail in Europe. These regulations often list this compound under Class 6.1 (toxic substances). Our teams review every consignment and reference safety data sheets to verify hazard classes before shipment leaves our facility.
Several countries impose specific requirements or even licensing on toxic organics shipped across borders. At times, regulations can differ not just by destination country but also by transport route, intermediary warehousing, or changes in logistics partners. Our regulatory specialists routinely consult customs documentation and maintain close communication with logistics partners in different geographies to avoid bottlenecks and missing paperwork. As manufacturers, we commit to auditing our chain of custody—ensuring traceability from source raw material to delivery point in accordance with local and international regulations.
Packaging and documentation play critical roles. Our standard packaging uses UN-approved, chemical-resistant containers, typically made from HDPE or steel drums with secure closures and tamper-evident seals. Labels on each drum prominently display hazard symbols matching the consignment’s shipping papers and Safety Data Sheet. All packaging passes leak tests and pressure checks before being cleared for loading.
Transport vehicles and freight forwarders must be licensed for dangerous goods and equipped with proper emergency response kits. Drivers and handlers receive DG training and follow routing rules that avoid congested or environmentally sensitive zones when mandated. International shipments require multiple layers of paperwork—declarations, manifests, certifications—checked and stamped by both authorities and our own staff.
Safe storage means maintaining controlled conditions well before transport begins. We keep 2,3-Dichloropyridine in well-ventilated, fire-resistant warehouses, isolated from incompatible substances like strong oxidizers or acids. Temperature is kept moderate, away from direct sunlight, to avoid possible decomposition or pressure build-up. Any accidental spillage is handled by teams trained in chemical response and equipped with adsorption and neutralization materials.
Shipping delays can arise from evolving regulatory requirements or regional differences in classifying hazardous chemicals. To mitigate risk, our compliance officers stay updated via regional government bulletins and chemical industry associations. When international standards differ from the most restrictive local laws, our policy is to adopt the stricter requirement as a baseline to avoid transit issues.
We continue to invest in staff training, maintain robust documentation trails, and use quality packaging to ensure every shipment of 2,3-Dichloropyridine reaches its destination safely and in compliance with global standards. As the manufacturer, we view regulatory and logistic complexity as part of our responsibility to clients, public safety, and long-term industry credibility.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales7@bouling-chem.com, +8615371019725 or WhatsApp: +8615371019725
